GELSOMINO, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 3.045
AS - Asia 2.541
EU - Europa 1.603
SA - Sud America 693
AF - Africa 191
Continente sconosciuto - Info sul continente non disponibili 144
OC - Oceania 7
Totale 8.224
Nazione #
US - Stati Uniti d'America 2.896
SG - Singapore 969
CN - Cina 524
BR - Brasile 520
VN - Vietnam 413
IT - Italia 375
UA - Ucraina 323
DE - Germania 269
AT - Austria 187
BD - Bangladesh 139
SE - Svezia 128
HK - Hong Kong 80
FR - Francia 78
SN - Senegal 78
IN - India 70
CA - Canada 64
AR - Argentina 56
FI - Finlandia 54
KR - Corea 53
GB - Regno Unito 46
MX - Messico 46
TR - Turchia 44
IQ - Iraq 38
ZA - Sudafrica 37
ID - Indonesia 31
PK - Pakistan 29
EC - Ecuador 28
RU - Federazione Russa 28
MA - Marocco 25
VE - Venezuela 21
CO - Colombia 20
MY - Malesia 19
NL - Olanda 18
CL - Cile 17
SA - Arabia Saudita 16
PL - Polonia 15
ES - Italia 14
AE - Emirati Arabi Uniti 13
UZ - Uzbekistan 13
BE - Belgio 12
TN - Tunisia 12
AZ - Azerbaigian 10
JP - Giappone 10
PY - Paraguay 10
DZ - Algeria 9
UY - Uruguay 9
CZ - Repubblica Ceca 8
EG - Egitto 8
JO - Giordania 8
PE - Perù 8
IL - Israele 7
JM - Giamaica 7
AL - Albania 6
AU - Australia 6
CR - Costa Rica 6
OM - Oman 6
PH - Filippine 6
DO - Repubblica Dominicana 5
EU - Europa 5
IR - Iran 5
KE - Kenya 5
NP - Nepal 5
SV - El Salvador 5
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
BO - Bolivia 4
CH - Svizzera 4
LT - Lituania 4
SY - Repubblica araba siriana 4
AM - Armenia 3
AO - Angola 3
GT - Guatemala 3
HN - Honduras 3
IE - Irlanda 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LB - Libano 3
LK - Sri Lanka 3
LV - Lettonia 3
PA - Panama 3
PS - Palestinian Territory 3
BY - Bielorussia 2
DK - Danimarca 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
HR - Croazia 2
LY - Libia 2
MD - Moldavia 2
NI - Nicaragua 2
PR - Porto Rico 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
SI - Slovenia 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
Totale 8.067
Città #
Singapore 354
Chandler 345
San Jose 290
Dallas 241
Ashburn 233
Council Bluffs 159
Ho Chi Minh City 148
Jacksonville 138
Vienna 134
Beijing 132
San Mateo 130
New York 122
Boardman 115
Hanoi 83
Hong Kong 80
Dakar 77
Munich 61
Santa Clara 58
Dearborn 55
Seoul 53
Shanghai 53
Los Angeles 51
Lauterbourg 48
São Paulo 46
Roxbury 44
Lawrence 43
Rende 40
Milan 39
Da Nang 30
Florence 30
Hefei 30
Helsinki 30
Brooklyn 28
Cosenza 27
Bremen 26
Des Moines 24
Ottawa 24
The Dalles 24
Columbus 23
Inglewood 23
Izmir 23
Rome 23
Ann Arbor 22
Turku 21
Haiphong 20
Orem 20
Johannesburg 19
Wilmington 19
Pune 17
Rio de Janeiro 17
Seattle 17
Toronto 17
Redwood City 16
Guangzhou 15
Curitiba 13
Kuala Lumpur 13
Ogden 13
Biên Hòa 12
Frankfurt am Main 12
Porto Alegre 12
Tashkent 12
Baghdad 11
Brussels 11
Chennai 11
Hải Dương 11
Mumbai 11
Quito 11
Warsaw 11
Amsterdam 10
Bari 10
Jakarta 10
Mexico City 10
Tianjin 10
Baku 9
Dhaka 9
Hillsboro 9
Lahore 9
Montreal 9
Tokyo 9
Buffalo 8
Chicago 8
London 8
Phoenix 8
Santiago 8
Belo Horizonte 7
Brasília 7
Catanzaro 7
Düsseldorf 7
Erbil 7
Fortaleza 7
Guarulhos 7
Guayaquil 7
Nanjing 7
Ninh Bình 7
San Francisco 7
Thái Bình 7
Boston 6
Campinas 6
Grafing 6
Medellín 6
Totale 4.373
Nome #
Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy 239
Activation of Farnesoid X Receptor Impairs The Tumor-Promoting Function of Breast Cancer-Associated Fibroblasts 205
Leptin and Notch Signaling Cooperate in Sustaining Glioblastoma Multiforme Progression 201
Analysis of circulating extracellular vesicle derived microRNAs in breast cancer patients with obesity: a potential role for Let-7a 195
Leptin Modulates Exosome Biogenesis in Breast Cancer Cells: An Additional Mechanism in Cell-to-Cell Communication 188
Adipocyte-derived extracellular vesicles promote breast cancer cell malignancy through HIF-1α activity 187
Aromatase Inhibitor Resistance in Breast Cancer: a Potential Role for Cytokine Signaling Network 185
The emerging role of adiponectin in female malignancies 185
Mutations in the estrogen receptor alpha hormone binding domain promote stem cell phenotype through notch activation in breast cancer cell lines 181
Evidence for enhanced exosome production in aromatase inhibitor-resistant breast cancer cells 181
A novel leptin antagonist peptide inhibits breast cancer growth in vitro and in vivo 176
Leptin Receptor as a Potential Target to Inhibit Human Testicular Seminoma Growth 175
Leptin Modulates Exosome Biogenesis in Breast Cancer Cells: an Additional Mechanism in Cell-to-Cell Communication 174
Uncoupling effects of estrogen receptor α on LKB1/AMPK interaction upon adiponectin exposure in breast cancer 172
Glucocorticoid Receptor as a Potential Target to Decrease Aromatase Expression and Inhibit Leydig Tumor Growth 167
Phosphodiesterase 5 (PDE5) is highly expressed in cancer-associated fibroblasts and enhances breast tumor progression 166
Knockdown of Leptin Receptor Affects Macrophage Phenotype in the Tumor Microenvironment Inhibiting Breast Cancer Growth and Progression 164
Farnesoid X Receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through down-regulation of HER2 expression 163
Interfering Role of ERα on Adiponectin Action in Breast Cancer 163
Phosphodiesterase 5 (PDE5) Expression and Function in Breast Cancer Stroma: an Attractive Opportunity for Targeted Therapy 161
Role of Phosphodiesterase 5 (PDE5) in Breast Cancer Stroma: Implications for Targeted Therapy 159
Estrogen Receptor-Positive Breast Cancer Cells Drive CAFs to Secrete Leptin and Support Tumor Invasiveness 156
Novel insights into adiponectin action in breast cancer: Evidence of its mechanistic effects mediated by ERα expression 155
Modulating Tumor-Associated Macrophage polarization by synthetic and natural PPARγ ligands as a potential target in breast cancer 154
Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer 150
Oldenlandia Diffusa extracts exert antiproliferative and apoptotic effects on human breast cancer cells through ERα/Sp1-mediated p53 activation 149
The Role of PPARγ Ligands in Breast Cancer: from Basic Research to Clinical Studies 148
Evidence that CRISPR-Cas9 Y537S-mutant expressing breast cancer cells activate Yes-associated protein 1 to driving the conversion of normal fibroblasts into cancer-associated fibroblasts 146
Novel insights into the antagonistic effects of losartan against angiotensin ii/agtr1 signaling in glioblastoma cells 145
Targeting thyroid hormone receptor beta in triple-negative breast cancer 135
Leptin mediates tumor-stromal interactions that promote the invasive growth of breast cancer cells 134
Development of a Leptin Antagonist Peptide: Implications for Breast Cancer 133
Adiponectin Influences the Behavior of Stem Cells in Hormone-Resistant Breast Cancer 132
May tumor microenvironment cooperate with a mutant ERalpha to promote breast cancer progression? 132
FXR ligands, by interfering with tumor/microenvironment crosstalk, inhibit breast tumor growth and progression. 129
Glucocorticoid Receptor as a Potential Target to Decrease Aromatase Expression and Inhibit Leydig Tumor Growth. 128
Leptin: A Heavyweight Player in Obesity-Related Cancers 127
ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling 126
Leptin Signaling Contributes to Aromatase Inhibitor Resistant Breast Cancer Cell Growth and Activation of Macrophages 126
Obesity, leptin and breast cancer: Epidemiological evidence and proposed mechanisms 123
Structural, Thermodynamic, and Kinetic Traits of Antiestrogen-Compounds Selectively Targeting the Y537S Mutant Estrogen Receptor α Transcriptional Activity in Breast Cancer Cell Lines 122
Obesity and endocrine therapy resistance in breast cancer: Mechanistic insights and perspectives 121
Natural and synthetic PPARγ ligands in tumor microenvironment: a new potential strategy against breast cancer 114
Hormonal modulation of ESR1 mutant metastasis 111
ERα/LKB1 complex upregulates E-cadherin expression and stimulates breast cancer growth and progression upon adiponectin exposure 111
Uncoupling effects of ERalpha on LKB1/AMPK signaling induced by adiponectin in breast cancer cells 106
The biology of exosomes in breast cancer progression: Dissemination, immune evasion and metastatic colonization 105
The Emerging Role of Extracellular Vesicles in Endocrine Resistant Breast Cancer 103
Tumor microenviroment cooperate with a mutant ERalpha to promote breast cancer progression? 97
CEBP-β and PLK1 as Potential Mediators of the Breast Cancer/Obesity Crosstalk: In Vitro and In Silico Analyses 92
May tumor microenvironment cooperate with a mutant ERα to promote breast cancer progression? 92
Proteomic Profiling of Extracellular Vesicles Released by Leptin-Treated Breast Cancer Cells: A Potential Role in Cancer Metabolism 89
Unraveling Obesity and Multiple Myeloma: Insights from Epidemiology and Molecular Mechanisms 85
TXNIP in cancer: Unlocking biological insights and tackling clinical challenges 85
miRNAs in the Box: Potential Diagnostic Role for Extracellular Vesicle-Packaged miRNA-27a and miRNA-128 in Breast Cancer 84
Complex Interplay Between Obesity and BRCA1/2-Associated Breast Cancer: An Overview 78
Extracellular vesicles in multiple myeloma-bone marrow niche crosstalk: from cellular dialogue to clinical perspectives 51
null 51
Adipocyte‑derived extracellular vesicles sustain mitochondrial metabolism in breast cancer cells: New insights into the cross‑talk between cancer cells and the tumor microenvironment 31
Adipocyte/Tumor cell crosstalk via IGF-1/TXNIP axis promotes malignancy and endocrine resistance in breast cancer 29
Interplay between Leptin and Stearoyl-CoA Desaturase 1 in Estrogen Receptor–Positive Breast Cancer Cells 27
Skin Carotenoid Score as a Potential Early Biomarker of Metabolic Syndrome Risk in Adolescents 25
Totale 8.224
Categoria #
all - tutte 40.313
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.313


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022625 0 107 6 79 57 10 1 145 9 3 70 138
2022/2023879 90 123 43 111 115 78 18 115 79 14 56 37
2023/2024659 74 39 54 31 42 161 15 63 45 28 29 78
2024/20251.227 82 120 23 74 72 63 69 82 193 98 111 240
2025/20263.822 361 165 422 232 684 307 374 260 315 227 206 269
2026/2027236 213 23 0 0 0 0 0 0 0 0 0 0
Totale 8.224